Recursion Pharmaceuticals Inc

Healthcare · Biotechnology

3.80$ +8.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Recursion Pharmaceuticals Inc (RXRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,213 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RXRX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	631	654	558	776	726	1,449	1,305	1,302	1,400	1,474	1,340	1,213
Current Assets	411	438	344	522	474	714	584	587	714	813	710	603
Cash	387	392	300	474	428	594	500	528	660	743	654	546
Cash & Short-Term Investments	387	392	300	474	428	594	500	528	660	743	654	546
Receivables	3.2	3.1	2.6	2.5	2.3	49	46	22	22	25	14	14
Inventory	2.3	–	–	–	–	–	–	–	–	–	–	–
Goodwill	53	52	52	52	52	149	158	164	162	162	160	160
Intangible Assets	39	36	33	38	34	336	336	341	322	310	294	283
Total Liabilities	193	190	157	191	202	414	371	383	353	343	315	298
Current Liabilities	94	93	74	86	109	187	142	164	155	148	130	120
Short-Term Debt	6.1	6.2	6.1	17	16	22	20	20	20	22	22	23
Accounts Payable	4.3	4.0	5.1	3.8	2.3	22	25	19	14	18	20	13
Long-Term Debt	1.1	1.1	1.1	23	21	19	16	14	12	9.6	7.2	4.8
Shareholders' Equity	438	463	401	584	525	1,035	934	919	1,047	1,131	1,025	915
Retained Earnings	-875	-968	-1,059	-1,157	-1,252	-1,431	-1,634	-1,806	-1,968	-2,076	-2,194	-2,325
Shares Outstanding	214	233	236	242	283	336	403	417	447	527	529	532

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings